Pulmonary Diseases and Clinical Allergology
- Comprehensive genomic profiling of Finnish lung adenocarcinoma cohort reveals high clinical actionability and SMARCA4 altered tumors with variable histology and poor prognosis (2022)
- Concepts for the development of person-centred, digitally-enabled, Artificial Intelligence-assisted ARIA care pathways (ARIA 2024) (2024)
- Consistency and reliability of smoking-related variables: longitudinal study design in asthma and COPD (2019)
- Continuous and Dichotomous Metabolic Syndrome Definitions in Youth Predict Adult Type 2 Diabetes and Carotid Artery Intima Media Thickness: The Cardiovascular Risk in Young Finns Study (2016)
- Contrasting healthcare costs of COPD and asthma in elderly (2023)
- Controlling chronic respiratory diseases in Finland from 1996 to 2018 (2022)
- COPD, chronic bronchitis and capability to day-to-day activities: population based study (2010)
- COST Action B26 Group. Management of obstructive sleep apnea in Europe. (2011)
- Costs of multidrug-resistant TB treatment in Finland and Estonia affected by the 2019 WHO guidelines (2021)
- CPAP-laitteen käytön ongelmatilanteet pitkäaikaishoidossa (2020)



